
1. Euro Surveill. 2021 Nov;26(45). doi: 10.2807/1560-7917.ES.2021.26.45.2100998.

Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown,
September 2021.

Benschop KS(1), Albert J(2)(3), Anton A(4), Andrés C(4), Aranzamendi M(5),
Armannsdóttir B(6), Bailly JL(7)(8), Baldanti F(9)(10), Baldvinsdóttir GE(6),
Beard S(11), Berginc N(12), Böttcher S(13), Blomqvist S(14), Bubba L(15), Calvo
C(16), Cabrerizo M(17), Cavallero A(18), Celma C(11), Ceriotti F(19), Costa
I(20), Cottrell S(21), Del Cuerpo M(22), Dean J(23), Dembinski JL(24), Diedrich
S(13), Diez-Domingo J(25), Dorenberg D(24), Duizer E(1), Dyrdak R(2)(3), Fanti
D(26), Farkas A(27), Feeney S(28), Flipse J(29), De Gascun C(23), Galli C(15),
Georgieva I(30), Gifford L(21), Guiomar R(20), Hönemann M(31), Ikonen N(14),
Jeannoël M(32), Josset L(32), Keeren K(33), López-Labrador FX(34)(25), Maier
M(31), McKenna J(28), Meijer A(1), Mengual-Chuliá B(25), Midgley SE(35), Mirand
A(7)(8), Montes M(5), Moore C(21), Morley U(23), Murk JL(36), Nikolaeva-Glomb
L(30), Numanovic S(24), Oggioni M(19), Palminha P(20), Pariani E(15),
Pellegrinelli L(15), Piralla A(10), Pietsch C(31), Piñeiro L(5), Rabella N(22),
Rainetova P(37), Uceda Renteria SC(19), Romero MP(15), Reynders M(37), Roorda
L(38), Savolainen-Kopra C(14), Schuffenecker I(32), Soynova A(30), Swanink
CM(29), Ursic T(39), Verweij JJ(36), Vila J(40), Vuorinen T(41), Simmonds P(42), 
Fischer TK(43)(44), Harvala H(45)(46).

Author information: 
(1)Center for Infectious Disease Control, National Institute for Public Health
and the Environment, Bilthoven, the Netherlands.
(2)Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet,
Stockholm, Sweden.
(3)Department of Clinical Microbiology, Karolinska University Hospital,
Stockholm, Sweden.
(4)Respiratory Virus Unit, Microbiology Department, Vall d'Hebron Institut de
Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
(5)Microbiology Department, Donostia University Hospital and Biodonostia Health
Research Institute, San Sebastián, Spain.
(6)Landspitali-National University Hospital, Reykjavik, Iceland.
(7)Université d'Auvergne, LMGE UMR CNRS 6023, Equipe EPIE - Epidémiologie et
physiopathologie des infections à entérovirus, Faculté de Médecine,
Clermont-Ferrand, France.
(8)CHU Clermont-Ferrand, National Reference Centre for enteroviruses and
parechoviruses - Associated laboratory, Clermont-Ferrand, France.
(9)Department of Clinical Surgical Diagnostic and Pediatric Sciences, Università 
degli Studi di Pavia, Pavia, Italy.
(10)Microbiology and Virology Department, Fondazione IRCCS Policlinico San
Matteo, Italy.
(11)UK Health Security Agency, Colindale, United Kingdom.
(12)National laboratory of health, environment and food, Laboratory for public
health virology, Ljubljana, Slovenia.
(13)National Reference Center for Poliomyelitis and Enteroviruses, Robert-Koch
Institute, Berlin, Germany.
(14)National Institute for Health and Welfare, Helsinki, Finland.
(15)Department of Biomedical Sciences of Health, University of Milan, Milan,
Italy.
(16)Hospital Universitario La Paz, Madrid, Spain.
(17)National Centre for Microbiology, Instituto de Salud Carlos III, Enterovirus 
and Viral Gastroenteritis Unit/Polio National Lab, Madrid, Spain.
(18)Laboratory of Microbiology, ASST Monza, San Gerardo Hospital, Monza (MB),
Italy.
(19)Virology Unit, Division of Clinical Laboratory, Fondazione IRCCS Ca' Granda
Ospedale Maggiore Policlinico, Milan, Italy.
(20)National Institute of Health (INSA), Lisbon, Portugal.
(21)Public Health Wales, Cardiff, United Kingdom.
(22)Microbiology Department Hospital Universitari de la Santa Creu i Sant Pau,
Universitat Autònoma de Barcelona, Barcelona, Spain.
(23)National Virus Reference Laboratory, University College Dublin, Dublin,
Ireland.
(24)Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
(25)Center for Public Health Research (FISABIO-Public Health), Generalitat
Valenciana, Valencia, Spain.
(26)Chemical-clinical and Microbiological Analyses, ASST Grande Ospedale
Metropolitano Niguarda, Milan, Italy.
(27)National Public Health Center, Budapest, Hungary.
(28)Regional Virus Laboratory, Belfast Health and Social Care Trust (BHSCT, Royal
Victoria Hospital, Belfast, United Kingdom.
(29)Laboratory for Medical Microbiology and Immunology, Rijnstate, Velp, the
Netherlands.
(30)National Reference Laboratory for Enteroviruses, National Center of
Infectious and Parasitic Diseases, Sofia, Bulgaria.
(31)Institute of Medical Microbiology and Virology, University of Leipzig,
Leipzig, Germany.
(32)National Reference Center for Enteroviruses and Parechoviruses, Institut des 
Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
(33)Secretary of the commission for Polio Eradication in Germany, Robert-Koch
Institute, Berlin, Germany.
(34)CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.
(35)The Danish WHO National Reference Laboratory for Poliovirus, Statens Serum
Institut, Copenhagen, Denmark.
(36)Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.
(37)National Institute of Public Health, Prague, Czech Republic.
(38)Maasstad Hospital, Rotterdam, the Netherlands.
(39)Institute of Microbiology and Immunology, Faculty of Medicine, University of 
Ljubljana, Ljubljana, Slovenia.
(40)Pediatric Hospitalization Unit, Department of Pediatrics, Hospital
Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona,
Spain.
(41)Clinical Microbiology, Turku University Hospital and Institute of
Biomedicine, University of Turku, Turku, Finland.
(42)University of Oxford, Oxford, United Kingdom.
(43)Nordsjaellands Hospital, Hillerod, Denmark.
(44)University of Sothern Denmark, Odense, Denmark.
(45)University College London (UCL), Department of infection and Immunity,
London, United Kingdom.
(46)NHS Blood and Transplant, Microbiology Services, Colindale, United Kingdom.

We report a rapid increase in enterovirus D68 (EV-D68) infections, with 139 cases
reported from eight European countries between 31 July and 14 October 2021. This 
upsurge is in line with the seasonality of EV-D68 and was presumably stimulated
by the widespread reopening after COVID-19 lockdown. Most cases were identified
in September, but more are to be expected in the coming months. Reinforcement of 
clinical awareness, diagnostic capacities and surveillance of EV-D68 is urgently 
needed in Europe.

DOI: 10.2807/1560-7917.ES.2021.26.45.2100998 
PMID: 34763750  [Indexed for MEDLINE]

